European air services, Air Italy and WOW air have started their direct flight service from India’s national capital New Delhi on Friday (8), the two airlines said. Both airlines are operating Airbus A330 planes.
Three Air Italy flights a week will fly from New Delhi to Milan from December 14. Also, there would be direct services between India’s commercial capital, Mumbai and Milan with three flights a week.
The long air service provider with low cost, WOW air is scheduled to run three direct flights from New Delhi to Reykjavik, the capital city of Iceland.
Air Italy's Chief Operating Officer Rossen Dimitrov said, the launch of its India-Italy sector represents another major step forward for the airline and reinforces its commitment to network expansion in Asia. He also added that India is a great market and there are "very high expectations" as there is an opportunity to grow.
WOW air India's Managing Director Kiran Jain said the response received from India has been overwhelming. "Our ultra-low fares reflect the need for affordable travel from India to transatlantic destinations," she noted.
The decision to start two long-distance air services from India to Europe shows a growing demand for air services. In October international passenger demand rose 6.3 per cent compared to October 2017, up from 5.1 per cent growth in September. Airlines in all regions recorded gains. Total capacity climbed 6.1 per cent, and load factor increased 0.1 percentage point to 79.8 per cent, according to the latest data released by the International Air Transport Association (IATA).
The global passenger traffic results for October showing that demand (measured in revenue passenger kilometres, or RPKs) rose 6.3 per cent compared to the same month last year. This marked a rebound from 5.5 per cent growth recorded in September, which was an eight-month low. Capacity also grew 6.3 per cent and load factor was flat at 81.1 per cent, matching last year’s record for the month, IATA added.
US president Donald Trump has again said that India is ready to cut 100 per cent tariffs on American goods and that a trade deal between the two countries is expected soon.
Speaking to Fox News, Trump said he is not in a "rush" to finalise the deal.
Commenting on Trump's remarks, India's external affairs minister S Jaishankar said in New Delhi on Thursday that any trade deal between the two countries must be mutually beneficial.
Trump referred to India as "one of the highest tariff nations in the world."
"They make it almost impossible to do business. Do you know that they're willing to cut 100 per cent of their tariffs for the United States?" he said.
When asked if the deal is coming soon, Trump said, "That'll come soon. I'm in no rush. Look, everybody wants to make a deal with us."
He added, "South Korea wants to make a deal but I'm not going to make deals with everybody. I'm just going to set the limit. I'll make another some deals. Because I can't, you can't meet with that many people. I've got 150 countries that want to make deals."
Talks are currently ongoing between India and the US to finalise a trade agreement.
On Thursday, Jaishankar said that negotiations were underway.
"These are complicated negotiations. Nothing is decided till everything is. Any trade deal has to be mutually beneficial; it has to work for both countries," he said. "That would be our expectation from the trade deal."
India's commerce minister Piyush Goyal is in Washington to assess the progress of the proposed trade agreement.
He is expected to meet US commerce secretary Howard Lutnick and US Trade Representative (USTR) Jamieson Greer.
India is looking for duty concessions on labour-intensive sectors including textiles, gems and jewellery, leather goods, garments, plastics, chemicals, shrimp, oil seeds, chemicals, grapes, and bananas.
The US is seeking duty concessions in areas such as industrial goods, automobiles (especially electric vehicles), wines, petrochemical products, dairy, and agricultural items like apples and tree nuts.
Tesco has issued an apology after a software problem caused disruptions to its website and mobile app, leaving some customers unable to manage online orders or access digital versions of their Clubcards.
The issue occurred on Friday afternoon, with users taking to social media to report problems ranging from being unable to amend their online grocery orders to difficulties accessing their Clubcard accounts. Some customers also reported being unable to use vouchers or collect points while shopping.
A Tesco spokesperson confirmed the incident had been resolved later that day. “We have fixed a software issue that temporarily impacted customers using our website and app this afternoon,” the spokesperson said. “We're sorry for the inconvenience.”
— (@)
Tesco's customer service team acknowledged the problem in responses on social media platform X (formerly Twitter), telling users the company was experiencing "intermittent system issues" and that its IT team was working to fix the situation.
Outage tracking site Downdetector reported a spike in issues with Tesco’s digital services shortly after 14:00 BST, with complaints gradually subsiding around two hours later. Some users, however, stated they had faced problems for up to four hours.
The disruption affected Tesco’s digital Clubcard system, which is used by millions of customers to access discounts and collect loyalty points. In early 2024, Tesco reported that its Clubcard scheme had over 20 million members across the UK.
Despite the timing of the outage and recent cyber attacks affecting other major UK retailers such as Marks and Spencer and the Co-op, there is no indication that Tesco’s problems were linked to a cybersecurity incident.
Tesco, the UK's largest supermarket chain, has not released further details on the nature of the software issue, but reassured customers that the matter had been addressed. Users experiencing ongoing problems have been advised to try again later or seek assistance via customer services.
Keep ReadingShow less
In April, Indian minister Ashwini Vaishnaw said that iPhones worth £13.22 bn were exported from India in FY25. (Photo: Reuters)
APPLE has assured the Indian government that its investment and manufacturing plans in the country remain unchanged.
This comes after US president Donald Trump said he had asked Apple CEO Tim Cook to scale back manufacturing in India and focus more on the United States.
Following this, Indian officials spoke to Apple executives, who confirmed that India would continue to be a major base for manufacturing Apple products, according to government sources quoted by PTI.
"Apple has said that its investment plans in India are intact and it proposes to continue to have India as a major manufacturing base for its products," a government source told the news agency.
Earlier, Trump had said he spoke to Cook and told him he does not want Apple to manufacture in India, urging the company to increase production in the US instead.
"We have Apple, as you know, it's coming in. And I had a little problem with Tim Cook yesterday. I said to him, Tim, you're my friend. I treated you very well. You're coming in with $500 billion (£375.94 bn). But now I hear you're building all over India. I don't want you building in India. You can build in India if you want to take care of India," Trump said.
He said India is one of the highest tariff nations and doing business there is difficult.
"They've (India) offered us a deal where basically they're willing to literally charge us no tariff. So we go from the highest tariff. You couldn't do business in India... But I said to Tim... we treated you really good. We put up with all the plants that you built in China for years. Now you got to build us. We're not interested in you building in India. India can take care of themselves. They're doing very well. We want you to build here. And they're going to be upping their production in the United States, Apple," Trump said.
Cook has said Apple will source most iPhones sold in the US from India in the June quarter. China will produce most of the devices for other markets amid uncertainty around tariffs.
Government sources said that 15 per cent of global iPhone production currently comes from India. Foxconn, Tata Electronics, and Pegatron India (largely owned by Tata Electronics) are involved in iPhone manufacturing.
Foxconn has also begun manufacturing Apple AirPods in Telangana for export.
An analysis by S&P Global showed that iPhone sales in the US reached 75.9 million units in 2024. Exports from India in March were at 3.1 million units, indicating a need to either expand capacity or redirect phones meant for the domestic market.
"Apple's Indian exports already headed predominantly to the United States, which represented 81.9 per cent of phones exported by the firm in the three months to February 28, 2025. That increased to 97.6 per cent in March 2025 as a result of a 219 per cent jump in exports, likely reflecting the firm looking to preempt higher tariffs," the S&P Global Market Intelligence report said.
In April, Indian minister Ashwini Vaishnaw said that iPhones worth £13.22 bn were exported from India in FY25.
The Apple ecosystem in India is also one of the largest job creators, with an estimated 2 lakh people employed across its vendor network.
(With inputs from PTI)
Keep ReadingShow less
Mittal, 74, has a net worth of more than £17.3 billion.
LAKSHMI MITTAL, executive chairman of ArcelorMittal SA and one of Britain’s richest residents, has purchased a mansion in Dubai’s Emirates Hills, known as the “Beverly Hills of Dubai”, Bloomberg reported, citing people familiar with the matter.
The Baroque-style home was listed for around £150 million in 2023 and sold for roughly half that amount earlier this year, according to people with knowledge of the deal.
The residence is lavishly decorated with gold leaf, the selling agent had said. Bloomberg reported the deal is among the most expensive residential sales in Dubai.
Mittal, 74, has a net worth of more than £17.3 billion, according to the Bloomberg Billionaires Index. The purchase comes as he considers leaving the UK following recent tax changes. A person familiar with the matter told Bloomberg that no final decision has been made yet.
The UK recently scrapped its preferential tax regime for non-domiciled residents, prompting several wealthy individuals, including Nassef Sawiris and Bart Becht, to relocate.
Mittal has been a prominent figure in UK business and politics for over two decades.
A representative for the Mittals told Bloomberg there are no plans to move their investment firm, LK Advisers, from London. The family continues to reside at their Kensington home.
Keep ReadingShow less
Dipesh Vaja, Raj Haria, Manish Shah, Miloni Tanna, Bharat Shah, Hatul Shah, Kamal Shah and Rajiv Shah at the 15th annual Sigma Conference in Baku, Azerbaijan
COMMUNITY pharmacy has a “vital role to play in rebuilding” the NHS, prime minister Sir Keir Starmer has said, referring to a recent announcement of record funding for the sector.
He said ministers want to capitalise on the clinical expertise of pharmacists as the Labour government is determined to fix the “broken” NHS inherited from successive Conservative administrations.
His remarks were delivered in a message to delegates at the 15th annual Sigma Conference in Baku, Azerbaijan.
“This government is developing a 10 Year Health Plan to reform the NHS to make it fit for the future,” said Starmer.
“Pharmacies play a key role in enabling the shift from hospital to community and from treatment to prevention.
“We are expanding their (community pharmacists) role by accelerating the rollout of independent prescribing to support this plan.”
An estimated 33 per cent of pharmacists are currently independent prescribers and, from September 2026, all newly qualified pharmacists will be independent prescribers on the day of registration.
As independent prescribers, pharmacists can take pressure off GPs and A&E services by assessing and diagnosing patients and, where necessary, prescribe medication for a range of clinical conditions, and vaccination programmes.
Hatul Shah
With more independent prescribers foraying into community pharmacy, NHS England plans to commission more clinical services to ensure patients have easier access to care and therefore reducing delays in treatment.
Independent prescribing builds on the Pharmacy First scheme, launched across England in January 2024; it lets patients receive treatment for seven common conditions directly from a pharmacist, without a GP appointment or prescription.
These include sinusitis, sore throat, earache, infected insect bite, impetigo, shingles and uncomplicated urinary tract infections in women.
“The Department of Health and Social Care recently announced a package that will see record investment and reform in order to support the sector,” Starmer told the Sigma conference.
“We’ve agreed with community pharmacy England to increase the community pharmacy contractual framework to £3.073 billion. This represents the largest increase in funding of any part of the NHS – more than 19 per cent across, 2024-2025 and 2025-2026 – which recognises that community pharmacy plays a vital role in our healthcare system.”
Among the 135 delegates were healthcare leaders and pharma industry representatives, who gathered in Baku to explore the theme ‘The future of the NHS through integrated leadership’.
British ambassador to Azerbaijan, Fergus Auld, said there was a huge demand for UK goods and services to support the growth of Azerbaijan’s fast developing health sector.
“With the government here very much focused on reform and investment, I’m proud to welcome all of you, but especially a fantastic business like Sigma to Azerbaijan for this important event and to support companies in expanding into this market,” said Auld.
Olivier Picard
“Sigma’s roots as a family-run business with 45 years of history in north London, growing to hundreds of employees supplying pharmacies across the UK with high quality and well-priced products is an inspiring story of growth in one of the UK’s most important sectors.”
Sigma Pharmaceuticals was founded by Dr Bharat Shah and his brothers Manish and Kamal.
Current CEO Hatul Shah said community pharmacy is becoming “a more integrated clinical and strategic partner in NHS delivery”. However, he stressed that community pharmacy needs more funding to meet the demands of delivering additional clinical services.
The pharmacy contract is still wellshort of the funding level recommended by a recent independent economic analysis of community pharmacy; it found the cost of providing NHS pharmaceutical services in England equated to £5.063bn. The report said nearly 80 per cent of pharmacies are “unsustainable” in the short term, with an estimated 800 having shut in the past four years.
“The recent contract announcement confirms the move towards a servicebased model is real. But, let’s be honest, it’s happening in a climate of flat funding, rising workload and intense workforce pressure,” said Hatul.
“Over the next few days, we’ll hear from people influencing the direction of NHS priorities, regulation and service expansion, but just as important, we’ll hear from you, those delivering care in the heart of community every day.
“This conference has always been about connection and clarity. It’s a space to reflect, to share practical ideas and to consider what comes next, not in theory, but in reality.
Fergus Auld speak on pharmacy’s evolving role
“Sigma remains committed to standing shoulder to shoulder with you, championing your voice, supporting your growth, and helping ensure that community pharmacy not only survives, but thrives.”
In his remarks, National Pharmacy Association (NPA) chair, Olivier Picard, described community pharmacy as “the most human profession that there is”.
Picard, himself the owner of four pharmacies, changed his business model from relying heavily on dispensing medicine to one that provides more services to the community it serves.
“It’s always been about the people, the service we offer, and our communities. I believe in our people and I believe in community,” he said. “When done right, pharmacy is probably the most human profession that there is.”
Picard said healthcare professionals across disciplines should work together to ensure the NHS can cater for the diverse needs of its patients.
“What I’m most proud of is the multidisciplinary approach in our pharmacies. We work with local pharmacists, nurses, paramedics to offer a wide range of NHS and private services,” he added.
“Community pharmacy has worked hard for years to establish themselves. We stayed open during the pandemic when so many others closed. Our future really lies at the heart of the NHS as an integrated part of offering NHS services.”